Could hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, Meric A.
dc.contributor.authorOzpinar, Aysel
dc.contributor.authorOzpinar, Alp
dc.contributor.authorHacker, Emily
dc.contributor.authorElmaci, Ilhan
dc.date.accessioned2025-10-16T15:23:12Z
dc.date.issued2019
dc.identifier.doi10.1111/1440-1681.13096
dc.identifier.otherWOS:000476681400002
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7951
dc.publisherWILEY
dc.sourceCLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
dc.subjectcancer
dc.subjectglioma
dc.subjectimmune
dc.subjectvaccine optimization
dc.titleCould hepatitis B vaccine act as an adjuvant to lower risk and relapses of cancer?
dc.typeReview

Dosyalar

Koleksiyonlar

WOS